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Over 55% of the world’s population lives in urban areas and this number is expected to reach almost 70% by 2050 (ref. 1), highlighting the importance of studying the drivers 
of health in cities2. Even areas of the world that were traditionally 
more rural (such as parts of Asia and Africa) are rapidly becoming 
more urban1. In parallel with the growth of urban populations it 
has become increasingly clear that designing and managing cities in 
ways that protect the environment is key to achieving environmen-
tal sustainability. Moreover urban policies, such as the promotion of 
active transportation or a shift toward renewable energies3, can have 
considerable environmental and health co-benefits4, which support 
a case for identifying the features of cities that are associated with 
better population health and that can be modified with appropriate 
policies5,6.
Despite growing urban populations, worldwide research on 
the health effects of urban living is sparse and often inconsistent7. 
Studies comparing urban to rural areas in different countries can 
be difficult to interpret due to variations in definitions of urbanicity 
across countries8,9. In addition, many of these studies do not iden-
tify specific features of urban living that are damaging or enhanc-
ing to health. Although many studies have documented differences 
in life expectancy and cause-specific mortality across countries10–13 
and, less frequently, across regions within countries14,15, few have 
investigated variations in health across cities and the factors 
associated with population health differences in these settings16,17. 
To our knowledge, no previous study has explored the heterogeneity 
in mortality and life expectancy outcomes in cities across multiple 
countries using comparable data.
City governments can directly affect population health in their 
municipalities, including mortality and environmental quality 
through implementation of appropriate urban policies. International 
organizations, such as UN-Habitat are increasingly calling for 
city-based and local initiatives, as well as recognition of cities as 
innovative, flexible and often progressive sites for policy-making 
to achieve the Sustainable Development Goals2,9; however, these 
actions must be based on evidence regarding what city-level fac-
tors are most important to health. Understanding the health conse-
quences of urban growth, urban landscape features (such as urban 
extent fragmentation) and city social features (such as access to 
water) can help inform urban policies to promote health9.
As one of the most urbanized regions of the world and with many 
diverse cities9, Latin America provides a unique setting in which to 
investigate differences in life expectancy and causes of death across 
cities, both within and between countries. Such analyses can offer 
insights into the drivers of differences in population health across 
cities and how urban policies might be used to enhance health 
in cities globally. We used data compiled by the Salud Urbana en 
América Latina (SALURBAL) study8,9 to: (1) describe the variability 
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in life expectancy and mortality profiles across Latin American cit-
ies in the period 2010–2016 and (2) investigate associations of city 
characteristics and life expectancy and mortality profiles.
Results
Heterogeneity in life expectancy across Latin American cities. 
Figures 1 and 2 show the distribution of life expectancy at birth in 
each of the 363 cities for men and women (Extended Data Fig. 1  
shows the distribution of life expectancy for men and women at 
20, 40 and 60 years of age). There was considerable heterogene-
ity in life expectancy across cities within each country, even when 
uncertainty in life expectancy estimation was accounted for: 41% 
and 46% of the total variability in life expectancy was within coun-
tries, in women and men, respectively (Supplementary Table 1). 
In men, the proportion of total variability that was within coun-
tries was higher for life expectancy at birth but was lower for life 
expectancy at ages 40 and 60 years. In women the proportion of the 
variability in life expectancy within countries did not vary as much 
across age and high variability persisted at ages 20, 40 and 60 years 
(Supplementary Table 1). We found that life expectancy at all ages, 
for both sexes and for all cities, was highly reliable with a relative s.e. 
(r.s.e. = s.e. / median life expectancy) <5% in all cases and <3% in 
the case of life expectancy at birth (Supplementary Fig. 1).
We found an 8- and 14-year range in life expectancy among the 
363 cities, with the lowest values at 74.4 (95% credible interval (CrI) 
73.7 to 74.9) and 63.5 (95% CrI 61.7 to 65.2) and the highest values 
at 82.7 (95% CrI 81.7 to 83.4) and 77.4 (95% CrI 75.3 to 78.9), in 
women and men, respectively (Figs. 1 and 2; city-specific data are 
available via the online interactive app https://drexel-uhc.shinyapps.
io/MS10/). Extended Data Fig. 2 compares the life expectancy of 
each city with the life expectancy by income group for the 2012–
2016 period, obtained from the 2019 United Nations Development 
Programme (UNDP) World Population Prospects18. For women, 
city life expectancy ranged from 74.4 to 82.7 years, which is slightly 
above that in middle-income countries (72.7 years) and slightly 
below that in high-income countries (83.1 years). Larger varia-
tion was observed for men, with city life expectancy ranging from 
63.5 to 77.4 years, which is below that in lower-middle-income 
countries (65.4 years) and slightly below that of high-income coun-
tries (77.7 years).
Within countries, the largest ranges in life expectancy were 
observed in Brazil and Peru for women (ranges of 6.4 years (75.6 
to 82.0) and 6.6 years (74.4 to 81.0), respectively) and in Brazil 
and Mexico for men (ranges of 8.6 years (66.3 to 74.9) and 10.4 
years (63.6 to 74.0 years), respectively). Life expectancy also var-
ied between countries, with Panama, Chile and Costa Rica having 
the cities with the longest life expectancy (81–82 years for women 
and 75–77 years for men). Mexico, Brazil and Peru had cities with 
the shortest life expectancy on average for women, at 77–78 years. 
Mexico and Brazil also had the shortest life expectancies for men, 
along with El Salvador, at 71 years on average. Figure 2 shows 
detailed spatial patterns of life expectancy in Latin America, with a 
North–South pattern in Brazil and Argentina and a coast-to-jungle 
pattern in Peru.
Predictors of life expectancy in Latin American cities. Table 1 
and Extended Data Fig. 3 show associations of urban characteristics 
with life expectancy at birth in multivariable models, scaled using 
s.d. to make coefficients comparable. Adjusted for other city-level 
indicators, the social environment index (a composite index of four 
indicators of area-level educational attainment, water and sew-
age access and overcrowding) predictive of longer life expectancy. 
Specifically, a 1 × s.d. higher social environment index was associ-
ated with a 0.78 and 0.48-year longer life expectancy in men and 
women, respectively. Moreover, we found that living in larger cities 
was associated with slightly shorter life expectancy among men and 
living in more fragmented cities (cities with a higher fragmentation 
of their urban extent, measured using the density of distinct urban 
patches) was associated with a longer life expectancy among both 
men and women. We also found that men living in cities with rapid 
population growth had longer life expectancy, but this association 
was not robust to the choice of the time period of population growth 
(Extended Data Fig. 4). Extended Data Fig. 3 shows the same set of 
associations for life expectancy at ages 20, 40 and 60 years, showing 
weaker associations especially in men. Extended Data Fig. 3 also 
shows unadjusted associations, where we found that the four sepa-
rate components of the social environment index are predictive of 
life expectancy.
Heterogeneity in mortality profiles across Latin American cities. 
There was considerable variability in proportionate mortality deaths 
by a specific cause over total deaths by cause across cities (Fig. 3). 
Proportionate mortality (the proportion of all deaths that is due to 
a given group of causes) by communicable, maternal, neonatal and 
nutritional (CMNN) conditions varied from 6% to 55%, propor-
tionate mortality by cancer varied from 9% to 30%, proportionate 
mortality by cardiovascular diseases (CVDs) and other noncom-
municable diseases (NCDs) varied from 28% to 71%, proportion-
ate mortality by unintentional injuries varied from 3% to 19% and 
proportionate mortality by violent injuries varied from 0% to 20% 
(Fig. 3, Extended Data Fig. 5 and Supplementary Table 2). CMNN, 
cancer and CVD/NCDs deaths varied more between countries than 
within countries (Supplementary Table 3; intraclass correlation 
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Fig. 1 | Variability in life expectancy at birth in 363 Latin American cities by country. Central line represents the median (50th percentile) city life 
expectancy, box limits represent the 25th and 75th percentiles and whiskers represent 1.5× the extent of the interquartile range. AR, Argentina; BR, Brazil; 
CL, Chile; CO, Colombia; CR, Costa Rica; MX, Mexico; PA, Panama; PE, Peru; SV, El Salvador.
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Mexican cities having a higher proportionate mortality by CMNN, 
cancer and CVD/NCDs, respectively, compared with other coun-
tries. However, injury deaths showed large within-country variabil-
ity (ICC = 38% for both unintentional and violent injuries), with 
cities ranging from 0% to 20% proportionate mortality by violent 
injuries in Mexico, Colombia and Brazil and from 4% to 19% pro-
portionate mortality by unintentional injuries in Peru and Brazil. 
Variability in age-adjusted proportionate mortality (AAPM) was 
similar (Extended Data Fig. 6), although within-country vari-
ability in violent deaths was reduced (ICC = 48%, compared to 
38% without age-adjustment; Supplementary Table 3), whereas 
within-country variability in unintentional injuries deaths was 
increased (ICC = 24% compared to 38%).
Extended Data Fig. 7 shows the spatial distribution of pro-
portionate mortality. CMNN, while highest in Peru overall, had 
its highest levels specifically in cities of the Peruvian jungle. 
Argentina, with relatively high levels of proportionate mortality by 
CMNN, had a higher proportionate mortality in the northwestern 
cities of the country. Proportionate mortality by cancer, highest 
in Chile, was also high in Southern Brazil and in the Argentinian 
Pampas. CVD/NCDs were highest in Mexico, specifically in the 
center and northeastern parts of the country. Unintentional inju-
ries were relatively high in cities in the Peruvian mountains and in 
North and Central Brazil, whereas violent injuries were highest in 
North and Northeastern Brazil, Southern Mexico and the Pacific 
coast of Colombia.
Predictors of cause-specific proportionate mortality in Latin 
American cities. Higher attainment of the social environment 
indicators (lower overcrowding, higher water and sewage access 
and higher educational attainment) were associated with a lower 
CMNN and injury proportionate mortality and a higher cancer and 
CVD/NCDs proportionate mortality. Figure 4 shows the associa-
tion of the social environment index with proportionate mortality 
(left) and AAPM (right): from the lowest to medium levels of social 
development, there is a sharp decrease in proportionate mortality 
by CMNN (20% to 15%) and an increase in CVD/NCDs (54% to 
56%) and cancer (13% to 16%). From the medium to the highest 
levels, there is a further decrease in CMNN proportionate mortality 
(15% to 10%), an increase in cancer proportionate mortality (from 
16% to 23%) and a decrease in unintentional injuries and violent 
injuries (from 7–8% to 4–5%). The pattern with AAPM was similar. 
Associations with higher educational attainment, water and sewage 
access and lower overcrowding were similar to the composite social 
environment index (Extended Data Figs. 8 and 9). Specifically, over-
crowding had a very strong and steep association with CMNN, with 
proportionate mortality by CMNN around 13% at the lowest levels 

















Fig. 2 | Spatial distribution of life expectancy at birth by city in 363 Latin American cities. The maps show life expectancy at birth for women (left) and 
men (right) in each city. The ranges (keys) are different for women and men.
Table 1 | Associations of city characteristics with life expectancy at birth among men and women in 363 Latin American cities
Variablea s.d. Men Women
City sizeb 50% larger cityb −0.09 (−0.2;0.03) 0.00 (−0.08;0.08)
City growth 2.7% growth/5 years 0.43 (0.23;0.62) 0.22 (0.08;0.36)
Population density 4,145 population km−2 −0.09 (−0.39;0.22) −0.02 (−0.24;0.20)
Fragmentation 0.3 urban patches km−2 0.28 (−0.02;0.58) 0.31 (0.10;0.53)
Street connectivity 6.4 intersections km−2 −0.27 (−0.85;0.31) 0.05 (−0.36;0.46)
Social environment index 1 × s.d. 0.78 (0.55;1.00) 0.48 (0.32;0.64)
Coefficients are differences in life expectancy (95% confidence intervals (CIs)), obtained from a linear mixed model of life expectancy, adjusted for the percentage of the administrative area of the city 
that is urbanized (Methods), with a random intercept for country, with all variables included in the same model. aVariables are defined in Methods and supplementary information. All variables are scaled 
by their s.d., so their coefficient is interpreted as the difference in life expectancy per s.d. increase in the variable. bCity size was log transformed and its coefficients are interpreted as the increase in life 
expectancy in cities that are 50% larger.
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Extended Data Figs. 8 and 9 also show proportionate mortal-
ity and AAPM, respectively, by other city-level factors. Cities with 
a higher age-adjusted mortality rate have a higher violent injury 
proportionate mortality and a lower cancer proportionate mortal-
ity. Larger cities have a higher violent injury proportionate mor-
tality, although this association was not observed for the largest 
cities in our sample. Cities with rapid growth have a higher CMNN 
and injury proportionate mortality and a lower cancer and CVD/
NCDs proportionate mortality. Denser cities have a higher violent 
injury proportionate mortality and CMNNs first increase but then 
decrease with density, whereas cities with a less-connected street 
network and a more fragmented urban extent have a lower CMNN 
and higher CVD/NCDs proportionate mortality.
Table 2 shows associations of each city-level predictor with pro-
portionate mortality for each cause relative to CVD/NCD, adjusted 
for all other predictors and age (Extended Data Fig. 10 shows a 
comparison for different sets of adjustments). Cities with higher 
all-cause age-adjusted mortality have relatively higher propor-
tionate mortality due to violent injury, whereas larger cities have 
higher violent injury proportionate mortality and lower uninten-
tional injury proportionate mortality. Dense cities had more violent 
deaths and less-fragmented and more-connected cities, along with 
cities with lower values of the social environment index, had more 
CMNN deaths, all relative to CVD/NCD deaths. While population 
growth was not associated with proportionate mortality, in sensitiv-
ity analysis using population growth in the 5 years before the study 
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Fig. 3 | Variability in proportionate mortality in 363 Latin American cities by country. Each column is a city, with each color representing the proportion 
of deaths due to each cause. Cities are grouped into countries. Countries are sorted by the overall proportion of violent deaths in the country and cities are 
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Fig. 4 | Social environment index and proportionate mortality by five causes in 363 Latin American cities. The range of the horizontal axis goes from the 
minimum to the maximum observed value of the social environment index. Ticks at the bottom of each plot represent observations (cities) with that value 
of the index. The white labels show proportionate mortality by each of the five causes by values of the social environment index (in five equal intervals).
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time (rather than concurrent with the study time), we found that 
population growth was associated with lower CMNN and cancer 
proportionate mortality (Extended Data Fig. 4). Sensitivity analy-
sis excluding cities with the highest proportion of ill-defined deaths 
showed no difference in results (Extended Data Fig. 10).
Discussion
Our findings demonstrate that life expectancy and mortality profiles 
are highly heterogeneous across Latin American cities. Life expec-
tancy at birth ranges from 74–83 years and 63–77 years in women 
and men, respectively. While countries such as Panama, Costa Rica 
and Chile have higher levels of life expectancy, in many countries 
there is large variability in life expectancy across cities within each 
country, sometimes as large as a difference of 7–10 years, as is the 
case with Mexico, Brazil, Colombia and Peru. We also found that 
social environment variables were predictive of life expectancy. 
The heterogeneity in mortality profiles between and within coun-
tries varied widely by cause. While NCDs were the most common 
cause of death and injuries were the least common, the proportion 
of deaths by each cause varied substantially across cities. We found 
that CMNN, cancer and CVD/NCD deaths varied more between 
countries and unintentional injuries and violent injuries deaths var-
ied more within countries. We also documented several important 
patterns regarding associations of city features with cause-specific 
mortality. We found that large and/or dense cities had a higher 
proportionate mortality by violent injuries and less-fragmented 
and more-connected cities had a higher proportionate mortality by 
CMNN. Cities with better social environment indicators had lower 
CMNN, whereas the association with CVD/NCDs and cancer var-
ied over the range of social environment values.
The usual conceptualization of the urban advantage in health7 
leaves an open question of whether health outcomes are similar 
across cities and whether there is a role for city-level factors as deter-
minants of health5. We have shown that there is large variability in 
life expectancy and proportionate mortality, even when considering 
cities in the same country.
Few studies have examined life expectancy at the city level 
across different countries. Cities in our sample with the lowest life 
expectancy at birth for men (63 years in Acapulco, Mexico), had 
life expectancies similar to Botswana and Myanmar, whereas the 
lowest city life expectancies for women (74–75 years in Acapulco, 
Acuña and Juarez in Mexico, Riohacha in Colombia and Chimbote 
in Peru) were similar to the life expectancy of cities in Egypt 
and Bangladesh. Cities with the highest life expectancy for men 
(77 years in Ica and Lima in Peru, San Jose in Costa Rica and Talca, 
La Serena and Santiago in Chile) were similar to high-income coun-
tries such as Portugal and Slovenia, whereas the highest life expec-
tancy for women (82–83 years in Los Angeles, Santiago, La Serena 
and Valparaiso in Chile and David in Panama) was similar to the 
United Kingdom and Germany (Fig. 2 shows a comparison with 
life expectancy by World Bank income groups, all for 2012–2016, 
obtained from the 2019 UNDP World Population Prospects)18.
With respect to mortality profiles, we observed heterogeneities 
across cities that differed by cause. For example, the range of pro-
portionate mortality by violent injuries varies from close to 0%, 
similar to that of Italy or Greece, to around 20%, similar to rates 
in Iraq13. Mortality by CVD/NCDs ranged from 28%, similar to 
Togo or Madagascar, to 71%, similar to Serbia or Romania13. The 
Global Burden of Disease study looked at variations between states 
within both India14 and Mexico15, but has not done so at a city level. 
While states are meaningful political units, cities can have more 
pronounced effects on health and mortality profiles through local 
urban policies19. The rise of municipalism and the coordinated 
efforts of cities across the world, offers the opportunity to develop 
tailored policies at the local level that draw strength from the spe-
cific particularities of each city, but that also acknowledge their con-
nections to other cities or parts of the world20.
We found that social environment indicators, including edu-
cation, access to water and sanitation and overcrowding, were 
strongly associated with life expectancy. This association has 
two potential explanations21: that these indicators are markers 
of improved living conditions and health-promoting services 
relevant to multiple causes of death across multiple ages or that 
these indicators capture processes specific to certain causes of 
death. For example improved sanitation and access to water are 
linked to lower rates of diarrhea and other communicable dis-
eases22, lower levels of overcrowding are linked to a lower rate of 
respiratory infections23 and increased area-level socioeconomic 
status is associated with lower cardiovascular disease mortality 
in US counties24. We found that these associations were weaker 
for life expectancy at ages 20, 40 and 60 years compared with life 
expectancy at birth, which is consistent with other literature from 
the region showing a lack of a social gradient in mortality for 
the elderly25.
Table 2 | Rate ratio (95%) for each group of causes of death (compared to CVD/other NCDs) associated with a 1 × s.d. increase in 
city-level factors, adjusted for all other city-level factors, the percentage of the administrative area of the city that is urbanized and 
the percentage of the population aged 15 years or below and 65 years or above




Mortalityb 94.3 deaths per 
100,000
0.99 (0.93;1.05) 0.88 (0.83;0.94) 1.00 1.01 (0.95;1.07) 1.27 (1.20;1.35)
City sizec 50% larger cityc 1.01 (0.95;1.08) 1.03 (0.97;1.10) 1.00 0.95 (0.89;1.01) 1.10 (1.03;1.18)
City growthb 2.7% growth in 5 
years
1.01 (0.96;1.07) 0.99 (0.94;1.05) 1.00 1.02 (0.96;1.08) 1.02 (0.96;1.08)
Population densityb 4,145 population km−2 1.00 (0.95;1.05) 1.03 (0.98;1.09) 1.00 1.02 (0.97;1.07) 1.17 (1.11;1.23)
Fragmentationb 0.3 urban 
patches km−2
0.86 (0.80;0.92) 0.96 (0.89;1.02) 1.00 0.96 (0.90;1.03) 1.04 (0.97;1.11)
Street connectivityb 6.4 intersections km−2 1.14 (1.00;1.30) 1.07 (0.95;1.22) 1.00 1.04 (0.91;1.18) 1.06 (0.93;1.21)
Social environment index 1 × s.d. 0.84 (0.80;0.89) 1.03 (0.97;1.08) 1.00 0.97 (0.92;1.02) 0.97 (0.92;1.02)
All variables are included in the same model. This analysis includes 362 cities, as Zarate-Campana in Argentina has no available street network data. bCoefficients are rate ratios (as compared to CVD/
NCDs) and 95% CIs, per s.d. increase in the variable. cCoefficients are rate ratios (as compared to CVD/NCDs) and 95% CIs, in a 50% larger city. aRefers to the scale of the variable (for example, mortality 
coefficients are interpreted per 107.8 deaths/100,000 people increase or 1 × s.d. of age-adjusted mortality rate). Ref., reference group (CVD/NCDs).
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Social environment variables also showed consistent associations 
with proportionate mortality. Higher levels of education attainment 
and water and sewage access and lower levels of overcrowding were 
associated with a higher proportion of cancer and CVD/NCDs and 
a lower proportion of CMNN. The higher proportion of NCDs in 
areas with improved markers of social environment is consistent 
with the epidemiological/demographic transition into stage 3 (ref. 
26), the stage of social development associated with an increase in 
mortality related to NCDs, highlighting the need for better NCD 
control strategies in these cities27.
Overall, cities with a better social environment had longer life 
expectancy (and therefore, lower overall levels of mortality) and 
higher mortality by NCDs, consistent with epidemiologic transition 
models26. However, as has been noted28, later stages in the epide-
miologic transition can also be characterized by large health inequi-
ties (which we have shown to be very wide in Latin America29) and 
by large heterogeneities in the proportion of deaths from injuries28. 
That we found no adjusted association of social environment indi-
cators with violence mortality (and only a weak negative associa-
tion with unintentional injuries) highlights that, at least for Latin 
American cities, injury mortality occurs at all levels of the social 
development spectrum.
We found that life expectancy was shorter for men living in large 
cities, but found no association for women. We also found that 
larger cities had a relatively higher proportionate mortality by vio-
lence compared with smaller cities. Given that in Latin America, 
violent deaths are strongly concentrated among young men, both 
results are consistent with a higher burden of violence in large cit-
ies. This is consistent with some previous research showing higher 
rates of violent crime in large cities both in the United States30 and 
in Brazil, Mexico and Colombia31. We also found that more frag-
mented cities had longer life expectancy and a relatively lower pro-
portionate mortality by CMNN, whereas cities with more densely 
connected street networks had proportionately higher CMNN. 
This is consistent with previous research on the relationship of 
the fragmentation of urban ecosystems and infectious diseases32,33. 
Last, cities with high population density had a higher proportionate 
mortality by violent injuries, especially comparing those of medium 
density versus low density, similar to research in the United States 
that found that increases in density at the low end of the spectrum 
are associated with higher violence34.
This study has several strengths. First, we included 5 years of 
data on all deaths and population of all 363 cities above 100,000 
people in nine Latin American countries, representing 283.3 mil-
lion people (almost half of the entire population of the region of 
Latin America and the Caribbean). These countries represent a 
wide variety of social and economic conditions, from lower-middle 
to high-income countries35. This constitutes a comprehensive effort 
to characterize life expectancies and mortality profiles across the 
universe of cities of these countries in Latin America. Second, we 
have harmonized and standardized mortality records in each city8 
and have tried to correct several issues that are present in analyses of 
vital registration records, including lack of complete coverage, using 
city-specific corrections. Third, we have also used categorizations of 
causes of death employed in previous studies, improving the gener-
alizability of our results8. Last, we have examined these associations 
using robust multilevel models, both univariable and multivariable, 
including nonparametric models. Future studies using these data 
will examine how various specific factors are related to changes 
in life expectancy over time, including air pollution, measures of 
income equality or characteristics of the healthcare system.
This study has a number of limitations. First, while we corrected 
for potential under-reporting of deaths by estimating complete-
ness at the city level, there is potential for this correction to not be 
enough or to be overcorrecting our mortality rates (increasing them 
spuriously). We implemented common demographic methods for 
the estimation of levels of coverage of mortality and used them in a 
way that maximizes adherence to assumptions36, especially the lack 
of migration assumption. Our analysis of proportionate mortality 
data should be robust to these biases, given that our estimates pro-
vide associations for the relative increase in certain causes of death 
compared to overall mortality, which should be robust to under-
counting providing that there is consistency in the under-reporting 
by cause of death. Second, the quality of data regarding age may also 
be problematic, as there is reported age over-estimation in mortal-
ity records, age-underestimation in population estimations and age 
heaping37. Third, we rely on the causes of death as coded in death 
certificates, where some deaths are coded as ill-defined38; however, 
we redistributed these to other causes using a proportional simple 
imputation based on age, sex, country and year38,39. Our sensitivity 
analysis to test the robustness of our results to a high proportion 
of ill-defined deaths showed no changes to our main inferences. 
Another limitation is the different timing in the measurement of 
social environment measures, for which we rely on censuses con-
ducted at different times in each country. Last, our analysis was 
conducted at the city level, so inferences about more granular levels 
(neighborhoods, households and individuals) are limited40.
There is large heterogeneity in life expectancy and mortal-
ity profiles across cities of Latin American countries. Population 
growth and social environment indicators are positively associated 
with life expectancy, whereas city size, growth and built and social 
environment features are associated with different causes of death. 
Characterizing heterogeneity of population health and factors that 
influence health across cities is the first step toward identifying risk 
factors that can be effectively modified by urban and health poli-
cies, as well as their implementation and continued monitoring for 
the region.
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Methods
Study setting. We conducted this study as a part of the SALURBAL project8,9, 
which has compiled and harmonized health, social and physical environment 
data on all cities with a population above 100,000 in 11 Latin American countries 
(Argentina, Brazil, Chile, Colombia, Costa Rica, El Salvador, Guatemala, Mexico, 
Nicaragua, Panama and Peru). The SALURBAL study protocol was approved by the 
Drexel University Institutional Review Board (ID no. 1612005035).
Cities of 100,000 people or more in 2010 were identified by combining 
information from the Atlas of Urban Expansion, census-based population data on 
administratively defined cities in each country and inspection of built-up areas on 
satellite maps8 Using this approach, 371 cities were identified and operationalized 
as clusters of the smallest administrative units for which disaggregated vital 
statistics data were available. More details on city selection and definition are 
available elsewhere8.
For this study, we used data on 363 cities in nine countries for which mortality 
and population data were available at the city level: Argentina, Brazil, Chile, 
Colombia, Costa Rica, El Salvador, Mexico, Panama and Peru. We summed 
deaths and population counts for each city during a 5-year period (2012–2016, 
except for El Salvador, which was 2010–2014 owing to restricted data availability). 
Nicaragua and Guatemala were excluded because of a lack of mortality data with 
georeferenced location of residence.
Data sources. We obtained mortality data from vital registration systems in each 
country. Mortality records included data on municipality of residence, age at death 
and cause of death coded using the International Classification of Diseases v.10. 
Population projections or estimations at the city level for every year from 2010 to 
2016 by age were obtained from national census bureaus. Data on predictors were 
obtained from vital statistics, population projections, censuses (latest available for 
every country), the Global Urban Footprint Project (2012), Worldpop (2010) and 
OpenStreetmap (2017). More details are available elsewhere8 and in Supplementary 
Tables 4–6.
Vital registration data. We addressed three challenges of vital registration. 
First, we imputed data with missing sex (~0.2%) and age (~0.5%) using a single 
conditional imputation. We imputed sex in each record with missing sex using the 
observed proportion of males in the same age (5-year groups) and cause of death 
strata for each country year. The same procedure was used for imputing age using 
sex and cause of death.
Second, we corrected for the lack of complete registration of all deaths at the 
city level, using an ensemble of death distribution methods41–43, stratified by sex. 
These methods estimate the degree of coverage of deaths using population by 
age at two points (coinciding with the study period) and deaths in the period in 
between. We estimated coverage using three different methods: generalized growth 
balance (GGB)44, synthetic extinct generations (SEG)45 and the hybrid method41. To 
address the assumption of lack of net migration, we used two strategies. First, we 
obtained the average of the coverage estimates, an approach that has been proposed 
to adequately account for migration flows to cities36,46. Specifically, we computed 
the harmonic mean of the GGB, SEG and hybrid methods46. Second, we calculated 
estimates of coverage for three age bands. First, we used the best-fitting age bands 
as provided by the DDM R package47, a method used before in Ecuador46. Second, 
we also used manually specified age bands, specifically the ages proposed by Hill36 
(30–65 years) and Murray43 (50–70 years), as these are age ranges where migration 
is lower than at younger ages. The combination of three methods and three age 
bands resulted in nine estimates of completeness per city, which we incorporated 
in our models as detailed below. Supplementary Fig. 2 shows the distribution of 
estimates of completeness of death counts by city and country.
Third, we redistributed deaths assigned to ill-defined diseases or injuries 
to specific causes of death38,39. We did this redistribution in three steps. First, 
for every 5-year age group, sex, country and year, we obtained the observed 
distribution of causes of death, diseases (CMNN, cancer and CVD/NCDs) and 
injuries (unintentional and violent). Second, for all deaths by an ill-defined 
disease in each 5-year age group, sex, country and year, we assigned a cause of 
death (CMNN, cancer or CVD/NCDs) using a single multinomial draw, with 
the observed probabilities from step 1. For all deaths by an injury of ill-defined 
intent in each 5-year age group, sex, country and year, we assigned a cause of death 
(unintentional or intentional) using a single multinomial draw, with the observed 
probabilities from step 1. Supplementary Table 2 and Supplementary Fig. 3 show 
the proportion of deaths by ill-defined diseases and by injuries of ill-defined intent 
by city and country. Ill-defined diseases represented 3% of all deaths and ranged 
from 0 to 32% by city, although 90% of the cities had <13% ill-defined deaths. 
Ill-defined deaths were highest in Argentina, Brazil and El Salvador (6%, 4% and 
15%, respectively). Injuries of ill-defined intent represented <0.1% of all deaths, 
ranged from 0 to 28%, although all but four cities had <5% of all deaths due to 
injuries of ill-defined intent.
City-level predictors. We purposively selected nine predictors available in routine 
data sources and that also captured three dimensions potentially amenable to 
urban policies: demographic features, urban form characteristics and social 
environment characteristics. Demographic features included city size (population) 
and city growth (population growth in the 5 years of the study). Age-adjusted 
all-cause mortality rate (using the 2000–2025 World Health Organization 
standard population) was also included as a covariate in analyses of proportionate 
mortality by cause. To characterize urban form, we used population density 
(population per area), fragmentation of the urban extent (density of urban patches) 
and connectivity (density of street intersections). To characterize the social 
environment, we used the proportion of the population aged 25 years or above 
that completed primary education and the proportion of households that were 
overcrowded, had water in the dwelling and connection to the sewage network. 
We also created a social environment index as the sum of the z scores of education, 
water access, sewage access and overcrowding (reversed). A higher level of the 
social environment index is a proxy for improved social conditions. All features 
refer to the administrative extent of the city. Supplementary Tables 4 and 5 show 
detailed definitions, operationalization and data sources for all indicators and 
Supplementary Table 7 shows a description by city size.
Estimation of life expectancy. Life expectancy is a widely used marker of the 
health of populations, as it summarizes mortality across ages and is a number that 
can be easily understood in terms of years of life10. To estimate life expectancy, 
we obtained estimates of age- and sex-specific mortality rates using a Bayesian 
Poisson model that draws information from country-level mortality patterns and 
age-specific mortality patterns. This model also incorporates uncertainty from 
the estimation of under-registration of death counts, following the approach of 
Schmertmann and Gonzaga48.
We let yi(j)k and ni(j)k denote the number of deaths in age group k from city j of 
country i, where k = 1,…17, i = 1,…9, j = 1,…Ji, and Ji denotes the number of cities 
in our dataset that belong to country i. To model these death counts, we assume
yi jð Þks  Pois ci jð Þsni jð Þksλi jð Þks
 
ð1Þ
where λi(j)ks denotes the city/age/sex-specific mortality rate and ci(j)s is a correction 
factor that measures the estimated proportion of deaths observed for each city and 
sex. Due to the potential for small counts in our data, we made use of Bayesian 
models to produce more precise estimates of the λi(j)ks. First and foremost, we write
log λi jð Þks ¼ β0ks þ αjs þ zi jð Þks ð2Þ
where β0ks denotes an age/sex-specific intercept term, αjs denotes a country-specific 
random effect and zi(j)ks is a random effect that permits the flexibility for each 
city to have its own trends in mortality across age groups. While sufficient data 
exist to produce stable estimates of the β0k parameters without informative 
prior structures, estimating the remaining parameters may require additional 
considerations. For instance, some countries have very few cities (for example, 
Costa Rica has only one city included in our study, Panama and El Salvador have 
three cities each); thus, to prevent overfitting we shrink the αjs toward each other by 





 controls the degree of shrinkage. To model 
the city-specific random effects, however, we require a more nuanced approach. 
In particular, while we want to let zi(j)ks vary by both city and age, the mortality 
schedules by age suggest that a simple linear trend in age would be inappropriate. 
However, we would also like to avoid sudden sharp increases or decreases in the 
zi(j)ks across age, instead favoring more smooth/gradual changes in age-specific 
mortality rates at the city level. Thus, we consider the use of an autoregressive 
structure for each city’s zi(j)ks where we assume
zi jð Þ1sjσ21s  Normð0; σ21sÞfor age � group 0� 1 ð3Þ
zi jð Þksjzi jð Þ;k�1;sσ2k  Normðρszi jð Þ;k�1;s; σ2ksÞfor age� groups>0� 1 ð4Þ
where ρs denotes a between-age correlation parameter and the σ2ks
I
 parameters 
facilitate between-city shrinkage in the zi(j)ks. Thus in our modeling approach, the 
city-specific mortality rate for a given age group is assumed to be centered around 
a value based on which country it belongs to (exp β0ks þ αjs
 
I
) with deviations from 
this trend being permitted when strong evidence exists (for example, greater than 
expected death counts among consecutive age groups).
We account for potential undercounting by following the approach of 
Schmertmann and Gonzaga48,49. We begin by calculating the nine completeness 
estimates described above (GGB, SEG and the hybrid GGB–SEG, by the three 
potential age bands, automatic, 30–65 and 50–70), which we denote c*i jð Þs;f
I
 for 
f ¼ 1; ¼ ; 9f g
I
. We then let ϕi(j)s denote the harmonic mean (as suggested by 
Peralta46),






andKi jð Þs ¼





s2i jð Þs ¼
X
f
c*i jð Þs;f � ϕi jð Þs
 
= 9� 1ð Þ
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represents the sample variance of the c*i jð Þs;f
I
 correction factors relative to their 
harmonic mean. We then let the correction factor in our model, ci(j)s, have a prior 
distribution of the form:




 which yields a prior whose expected 
value is ϕi(j)s and variance is s2i jð Þs
I
, as desired. It should be noted that our goal is not 
necessarily to learn about the ci(j)s but rather to account for the uncertainty in our 
estimate of the true proportion of undercounting in the data.
This model was fitted using iterative Markov chain Monte Carlo (MCMC) 
using the JAGS program. The estimation for the model starts with 50,000 burn-in 
MCMC iterations that allow the chain to converge, followed by 100,000 MCMC 
iterations. To reduce autocorrelation we thinned these samples by a factor of 100 
to obtain 1,000 complete sets. We obtained a sample of 1,000 complete sets of 
age- and sex-specific mortality rates (λ) from these iterations. From this model, 
we obtained a complete set of 1,000 age- and sex-specific mortality rates that were 
used henceforth. Finally, we calculated a set of 1,000 life expectancies for each city 
and sex using life tables, both at birth and at ages 20, 40 and 60 years, using the 
DemoTools R package50 (lt_abridged function).
Mortality profiles. Mortality profiles by cause of death were operationalized using 
cause-specific proportionate mortality, estimated as number of deaths in a specific 




Where PMij is the proportionate mortality for the ith cause in the jth city and 
deathsij are the number of deaths due to the ith cause in the jth city. Deaths were 
categorized using the Global Health Estimates classification51 and then grouped 
into five categories: (1) CMNN; (2) cancer; (3) CVD/NCDs; (4) unintentional 
injuries; and (5) violent injuries. Supplementary Table 8 contains a comprehensive 
list of International Classification of Diseases codes included in each category. 
In secondary analyses, we also calculated an AAPM, by using cause-specific 





In descriptive analysis, to account for the lack of complete registration of all 
deaths, we upweighted deaths by the correction factor (corrected deaths = observed 
deaths / coverage). For the multilevel models, we downweighed population by 
the correction factor to avoid increasing the precision of our estimates artificially 
(corrected population = observed population × coverage).
Statistical analysis. The main objectives of this analysis were to describe 
heterogeneity in life expectancy and mortality profiles between Latin American 
cities and to estimate associations with city-level factors.
To describe variability in life expectancy, we created graphical depictions of 
life expectancy by city and country, showing the median and (where appropriate) 
95% CrIs of life expectancy for each city. We also calculated and plotted the r.s.e., a 
measure of the sampling variability of life expectancy. We considered an estimate 
reliable if r.s.e. < 25%52.
We also decomposed the variability in life expectancy into: (1) differences 
between the 1,000 iterations within each city; (2) differences between cities within 
a country; and (3) differences between countries using a three-level linear mixed 
model with life expectancy as the dependent variable and a random intercept for 
country and city:
Life Expectancyijk ¼ α000 þ μ00k þ μ0jk þ ϵijk
μ00k  N 0; τ000ð Þ; μ0jk  N 0; τ00ð Þ; ϵijk  N 0; σ2ð Þ;
Where life expectancyijk is the life expectancy for each ith iteration in the jth city in 
the kth country, α000 is the overall mean life expectancy, μ00k is the deviation of each 
country mean from the overall mean, μ0jk is the deviation of each city’s mean from 
the country mean and εijk is the deviation for each iteration from the city mean. 
These three random effects (country random intercept, city random intercept 
and iteration residuals) are distributed normally with variances τ000, τ00 and σ2, 
respectively. We calculated how much of the total variance (τ000 + τ00 + σ2) was at the 
iteration level (σ2 / total variance), city level (τ00 / total variance) and country level 
(τ000 / total variance). The linear mixed model to decompose variance was weighted 
by the population of each city at baseline. We also computed ranges (max–min) for 
life expectancy for each country, age and sex combination, to assess the variability 
for specific countries.
To describe heterogeneity in mortality profiles across cities we created 
graphical depictions of proportionate mortality and computed ICCs to describe 
between- versus within-country variability, using a linear mixed model with each 
proportionate mortality as the outcome and a random intercept for country.
To estimate the univariable association of city-level predictors with life 
expectancy, we ran set of a linear mixed models with life expectancy as the 
outcome, a random intercept for country and a single predictor in each model. 
This model provides a descriptive look at the variation in life expectancy by levels 
of city size, physical environment and social environment variables. The linear 
mixed model was run 1,000 times (with the 1,000 estimated life expectancies for 
each city) and then coefficients were pooled using Rubin’s formula53. We also ran 
a multivariable model with all urban form variables and the social environment 
index. This model provides a description of the variation in life expectancy by 
levels of each predictor, adjusted for all other predictors.
We examined the association of city-level factors with proportionate mortality 
using two approaches. First, we used a nonparametric approach to describe the 
association of each city-level factor with proportionate mortality by each group 
of causes of death. We computed a LOWESS smoother of each proportionate 
mortality on the city-level factor. We then created stacked area plots showing  
the estimated levels of proportionate mortality for the range of levels of the 
city-level predictor.
Second, to provide an estimate of the strength of these associations, we fitted 
a three-level negative binomial multilevel model for aggregated data, where each 
observation was a cause of death–city–country combination, with an offset for 
log(population), a random intercept for city and country. The model includes a 
set of four indicator variables for cause of death, the variable of interest and an 
interaction term between causes of death and the exposure. The exponentiated 
interaction coefficients represent the relative increase in the proportion of 
deaths by a specific cause as compared to CVD/NCDs per one-unit increase in 
the predictor. We fitted these models at different adjustment levels: (1) a model 
with each predictor investigated separately (univariable model); (2) a univariable 
model + adjustment for the percentage of the population under 15 and above 65 
(age-adjusted univariable model); (3) a univariable model adjusted for age and 
all-cause mortality, to evaluate the sensitivity of the estimates to heterogeneity 
in the absolute levels of mortality rates; and (4) a multivariable model with all 
predictors included in the same model, along with age. In the multivariable 
models we included only the social environment index instead of including all 
social environment indicators to avoid collinearity between social environment 
indicators.
In all models above, and to make coefficients comparable, all variables were 
centered by their overall mean scaled by their overall s.d., except for population, 
which was log transformed. All analyses that used built environment variables 
(density, fragmentation, connectivity) were adjusted for the proportion of the 
administrative area that is urbanized (covered by urban patches8), to avoid 
measurement misclassification of built environment variables due to the definition of 
the administrative area and to standardize cities by the size of the administrative area.
We ran two secondary analyses. First, we repeated the analysis in the restricted 
set of cities in which we had data on population growth 5 years before the study 
period, instead of concurrent with the study period, to compare associations of 
population growth during and before the study period. Second, we ran the analysis 
of predictors of proportionate mortality in the restricted set of cities with a lower 
proportion of ill-defined deaths (defined as <90th percentile or 13% ill-defined 
deaths).
We do not report P values to prevent ‘P hacking’ and as our goal was not to test 
hypotheses but rather to report point estimates and levels of precision by the 95% 
CI.40 Data harmonization and cleaning was conducted in R v.4.0.0 and SAS v.9.2. 
All analyses were conducted in R v.4.0.0 and JAGS v.4.
Reporting Summary. Further information on research design is available in the 
Nature Research Reporting Summary linked to this article.
Data availability
Life expectancy and proportionate mortality data with city identifiers are freely 
available from the interactive app at https://drexel-uhc.shinyapps.io/MS10/. 
Vital registration data for Brazil, Chile, Colombia and Mexico were downloaded 
from publicly available repositories from statistical agencies in each country. 
Vital registration data for Argentina, Costa Rica, El Salvador, Panama and 
Peru were obtained directly from statistical agencies in each country. A link to 
these agency websites can be accessed via https://drexel.edu/lac/data-evidence/
data-acknowledgements/. Source data are provided with this paper.
Code availability
Code used in this study is available at https://github.com/usamabilal/
SALURBAL_MS10.
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Extended Data Fig. 1 | See next page for caption.
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Extended Data Fig. 1 | Variability in Life expectancy at Birth, Ages 20, 40 and 60, in 363 Latin American cities by Country. Solid triangles represent the 
life expectancy at the country level for 2012–2016 (2010–2014 for El Salvador), as obtained from UNDP’s World Population Prospects (2019 version).  
The boxplot’s central line represents the median (50th percentile) city life expectancy, box limits represent the 25th and 75th percentiles, and whiskers 
represent 1.5 times the extent of the interquartile range. AR: Argentina, BR: Brazil, CL: Chile, CO: Colombia, CR: Costa Rica, MX: Mexico, PA: Panama,  
PE: Peru, SV: El Salvador.
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Extended Data Fig. 2 | Life expectancy at birth in 363 Latin American cities and reference lines for 2012–2016 life expectancy by income group. Dashed 
lines represent life expectancy for World Bank income groups for 2012–2016, obtained from UNDP’s World Population Prospects (2019 version). Points 
represent life expectancy at birth in each city and error bars represent the 95% credible intervals of life expectancy at birth in each city.
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Extended Data Fig. 3 | Results of the multivariable model with life expectancy at birth, 20, 40 and 60 years of age in 363 Latin American cities. Shown 
are regression coefficients and 95% confidence intervals. Horizontal dashed line represents the null effect.
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Extended Data Fig. 4 | Results of secondary analysis using city growth in the 5 years previous to study period (instead of concurrent), in 363 Latin 
American cities. Shown are regression coefficients and 95% confidence intervals. Horizontal dashed line represents the null effect.
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Extended Data Fig. 5 | Variability in Proportionate Mortality in 363 Latin American Cities. Each dot represents a city.
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Extended Data Fig. 6 | Age-adjusted proportionate mortality by city in 363 cities of 9 Latin American countries. Each column is a city, with each color 
representing the proportion of deaths due to each cause. Cities are grouped in countries. Countries are sorted by the overall proportion of violent deaths in 
the country, and cities are sorted within country by the proportion of violent deaths in each city. CVD and other NCDs: cardiovascular diseases and other 
non-communicable diseases.
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Extended Data Fig. 7 | Spatial distribution of proportionate mortality in 363 Latin American cities.
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Communicable/Maternal/Neonatal/Nutritional Cancer CVD and other NCDs
Unintentional Injuries Violent Injuries
Extended Data Fig. 8 | Predictors Proportionate Mortality by 5 causes in 363 Latin American Cities. The range of the horizontal axis goes from the 
minimum to the maximum observed value of each indicator. Ticks at the bottom of each plot represent observations (cities) with that value of each 
indicator. The white labels show proportionate mortality by each of the 5 causes by values of each indicator in 5 equal intervals. CVD and other NCDs: 
cardiovascular diseases and other non-communicable diseases.
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Extended Data Fig. 9 | Predictors of Age-Adjusted Proportionate Mortality by 5 causes in 363 Latin American Cities. The range of the horizontal axis 
goes from the minimum to the maximum observed value of each indicator. Ticks at the bottom of each plot represent observations (cities) with that value 
of each indicator. The white labels show proportionate mortality by each of the 5 causes by values of each indicator in 5 equal intervals. CVD and other 
NCDs: cardiovascular diseases and other non-communicable diseases.
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Extended Data Fig. 10 | Rate Ratio for each group of causes of death (compared to CVD/Other NCDs) associated with a 1SD increase in city-level 
factors for six different levels of adjustment in 363 Latin American cities. Coefficients are Rate Ratios (As compared to CVD/NCDs), and error bars 
are their corresponding and 95% CIs, per standard deviation increase in each variable (except for city size, where they correspond to a 50% larger city). 
Univariable model contains each variable in a different model, adjusted for % built-up (see methods). Univariable models adjusted for age contain a 
covariable for % under 15 and % above 65, and univariable models adjusted for mortality contain a covariable for all-cause age-adjusted mortality rate. 
Multivariable models contain all predictors in the same model. The model restricted by % ill-defined deaths restricts the analysis to cities with <13% 
ill-defined deaths (90th percentile).
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